Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease - Concepedia

Concepedia

Publication | Open Access

Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease

DOI Full Paper Access

126

Citations

54

References

2017

Year

Juliane Totzke, Deepak Gurbani, Rene Raphemot, Philip F. Hughes, Khaldon Bodoor, David A. Carlson, David R. Loiselle, Asim K. Bera, Liesl S. Eibschutz, Marisha M. Perkins,

Cell chemical biology

Selective Tak1 InhibitorCancer ImmunosurveillanceAutoimmune DiseaseTnf-α InhibitionImmunologyTumor ImmunityImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorImmunotherapeuticsImmunotherapyMedicineRadiation OncologyNovel Therapy

References

	Year	Citations

Page 1

Page 1